Nimverta, a Zurich-based biotech startup,has secured Venture Kick’s Stage-2 funding and initial Innosuisse coaching support, marking a new phase in its mission to develop first-in-class peptide therapies for bone regeneration.
Nimverta Secures Venture Kick Support to Advance Bone Regeneration Therapy
- Venture Kick Newsroom
- Wednesday, Sep 17, 2025